NCT02131012View on ClinicalTrials.gov

Intravitreal Celecoxib for Chronic Uveitis

PHASE1TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 1, 2016

Study Completion Date

November 1, 2016

Conditions
Inflammation
Interventions
DRUG

Intravitreal Celecoxib

1-4 mg intravitreal celecoxib

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Vanderbilt University

OTHER

NCT02131012 - Intravitreal Celecoxib for Chronic Uveitis | Biotech Hunter | Biotech Hunter